Status:
COMPLETED
Intestinal Response Patterns to Microbial Signals
Lead Sponsor:
Sheba Medical Center
Collaborating Sponsors:
Weizmann Institute of Science
Washington University School of Medicine
Conditions:
CD - Crohn's Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A cohort of CD patients (total n=300) and a cohort of controls (healthy individuals and family members of CD patients, total n=200) will be recruited. We will analyze gut host pattern of tissue immun...
Detailed Description
Only adults\>18YO will be included, Two cohorts will be included: A cohort of CD patients (including specific sub-cohorts of recruited known \& new-onset CD and travelling CD patients and archived pat...
Eligibility Criteria
Inclusion
- adults\>18YO
- CD patients: known CD\\ new-onset CD\\ travelling CD or controls: healthy individuals\\ family members of CD patients
Exclusion
- Age\<18YO
- pregnant women
- inability to provide informed consent
- drug/alcohol abuse
Key Trial Info
Start Date :
November 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2023
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT03872622
Start Date
November 27 2018
End Date
August 29 2023
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Ramat Gan, Israel, 580301992